Nivolumab-induced thyroid dysfunction in patients with lung cancer.

Ramos-Levi, Ana M

Nivolumab-induced thyroid dysfunction in patients with lung cancer. [electronic resource] - Endocrinologia, diabetes y nutricion Jan 2019 - 26-34 p. digital

Publication Type: Journal Article

2530-0180

10.1016/j.endinu.2018.05.005 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Nivolumab--adverse effects
Retrospective Studies
Risk Assessment
Risk Factors
Thyroid Diseases--chemically induced